Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons

BACKGROUND: Little is known about the comparative effectiveness of atypical antipsychotics in long-acting injection formulation. Due to the absence of head-to-head studies comparing olanzapine long-acting injection and risperidone long-acting injection, this study was intended to make exploratory, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascher-Svanum, Haya, Montgomery, William S, McDonnell, David P, Coleman, Kristina A, Feldman, Peter D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355848/
https://www.ncbi.nlm.nih.gov/pubmed/22615534
http://dx.doi.org/10.2147/IJGM.S29052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355848/
https://www.ncbi.nlm.nih.gov/pubmed/22615534
http://dx.doi.org/10.2147/IJGM.S29052

Ejemplares similares